IRIS
CIABATTINI, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.649
EU - Europa 5.606
AS - Asia 2.939
SA - Sud America 517
AF - Africa 168
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.888
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.530
IT - Italia 1.334
RU - Federazione Russa 1.240
SG - Singapore 923
CN - Cina 902
GB - Regno Unito 712
IE - Irlanda 637
BR - Brasile 415
DE - Germania 333
VN - Vietnam 328
SE - Svezia 317
FI - Finlandia 274
FR - Francia 271
HK - Hong Kong 246
UA - Ucraina 216
KR - Corea 166
IN - India 102
ZA - Sudafrica 98
CA - Canada 67
BD - Bangladesh 58
ES - Italia 48
PL - Polonia 42
NL - Olanda 40
AR - Argentina 34
IQ - Iraq 28
MX - Messico 27
UZ - Uzbekistan 24
BE - Belgio 23
JP - Giappone 20
TR - Turchia 20
AT - Austria 19
CH - Svizzera 17
VE - Venezuela 17
CZ - Repubblica Ceca 14
NG - Nigeria 14
ID - Indonesia 13
IR - Iran 13
GR - Grecia 12
CI - Costa d'Avorio 11
EC - Ecuador 11
IL - Israele 10
LT - Lituania 10
SA - Arabia Saudita 10
CL - Cile 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
PT - Portogallo 8
CO - Colombia 7
JO - Giordania 7
MA - Marocco 7
PE - Perù 7
PY - Paraguay 7
SI - Slovenia 7
AZ - Azerbaigian 6
BO - Bolivia 6
EG - Egitto 6
ET - Etiopia 6
MY - Malesia 6
TH - Thailandia 6
AU - Australia 5
DO - Repubblica Dominicana 5
NP - Nepal 5
PH - Filippine 5
RO - Romania 5
AL - Albania 4
GE - Georgia 4
HN - Honduras 4
JM - Giamaica 4
KZ - Kazakistan 4
TN - Tunisia 4
CR - Costa Rica 3
DK - Danimarca 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
UY - Uruguay 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
MD - Moldavia 2
MT - Malta 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
ZM - Zambia 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
GD - Grenada 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
Totale 14.869
Salva come PNG Salva come JPEG
Città #
Dallas 718
Dublin 636
Southend 553
Singapore 514
Ashburn 489
Fairfield 481
Chandler 332
Moscow 330
San Jose 296
Santa Clara 296
Milan 274
Siena 265
Beijing 234
Hong Kong 232
Woodbridge 219
Hefei 195
Jacksonville 175
Ann Arbor 161
Seattle 160
Seoul 159
Cambridge 155
Helsinki 154
Houston 153
Munich 144
Wilmington 140
Rome 131
Los Angeles 124
New York 104
Princeton 97
Council Bluffs 96
Johannesburg 85
Ho Chi Minh City 80
Florence 78
The Dalles 77
Lauterbourg 75
Hanoi 72
Dong Ket 68
Lappeenranta 64
Nanjing 58
São Paulo 45
Orem 40
Buffalo 34
Shanghai 33
London 32
San Mateo 32
Boardman 28
Frankfurt am Main 28
San Diego 27
Montreal 25
Brussels 23
Denver 22
Menlo Park 22
Turku 22
Bengaluru 21
Chicago 21
Düsseldorf 21
Nuremberg 21
Shenyang 21
Tashkent 21
Chennai 20
Tokyo 20
Phoenix 19
Redondo Beach 19
Warsaw 19
Lancaster 18
Figino 17
Toronto 17
Málaga 16
Washington 16
Bologna 15
Columbus 15
Nanchang 15
San Francisco 15
Belo Horizonte 14
Dearborn 14
Messina 14
Piscataway 14
Atlanta 13
Fremont 13
Guangzhou 13
Haiphong 12
Hebei 12
Mumbai 12
Portsmouth 12
Abidjan 11
Abuja 11
Amsterdam 11
Kunming 11
Naples 11
Paris 11
Redwood City 11
Baghdad 10
Brescia 10
Brooklyn 10
Changsha 10
Da Nang 10
Madrid 10
Rio de Janeiro 10
Brno 9
Cape Town 9
Totale 9.762
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 367
Vaginal immunization to elicit primary T-cell activation and dissemination 332
Vaccination in the elderly: The challenge of immune changes with aging 318
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 317
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 306
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 300
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 297
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 290
Ebola vaccine R&D: Filling the knowledge gaps 283
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 279
Adoptive transfer of transgenic T cells to study mucosal adjuvants 279
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 264
Role of the microbiota in the modulation of vaccine immune responses 264
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 251
Bacillus spores for vaccine delivery 243
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 241
Modulation of Primary Immune Response by Different Vaccine Adjuvants 240
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 240
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 233
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 218
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 216
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 216
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 210
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 208
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 205
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 203
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 202
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 202
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 200
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 199
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 198
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 194
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 194
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 190
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 190
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 190
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 188
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 188
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 184
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 183
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 182
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 181
Primary T-cell response to mucosal vaccination 181
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 181
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 179
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 178
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 177
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 177
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 176
Oral priming of mice by recombinant spores of Bacillus subtilis 172
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 172
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 170
Surface display of recombinant proteins on Bacillus subtilis spores 170
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 168
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 164
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 161
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 159
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 158
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein 158
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 158
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 157
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 151
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study 150
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 149
Primary activation of CD4+ and CD8+ T cells following mucosal vaccination with recombinant bacteria 142
Oral priming of mice using recombinant spores of Bacillus subtilis 140
Expression of immunomodulating molecules on the surface of the vaccine vector Streptococcus gordonii 133
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 132
Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers 124
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP 123
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 117
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach 116
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 114
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2 114
null 102
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 101
Machine learning approaches to dissect hybrid and vaccine-induced immunity 23
Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial 20
Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome 17
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae 14
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV 12
Totale 15.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.483
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022837 64 127 43 59 29 14 44 28 44 80 115 190
2022/20231.223 77 142 173 136 103 220 41 104 88 31 81 27
2023/20241.202 33 34 100 79 55 307 367 43 24 65 25 70
2024/20252.606 80 97 271 138 313 166 144 161 269 111 244 612
2025/20265.946 459 796 593 763 1.079 217 586 188 250 359 204 452
2026/2027114 114 0 0 0 0 0 0 0 0 0 0 0
Totale 15.095